Showing results (171-180 of 191) with videos related to

Sort By:
Pageof 20
Hepatology (Baltimore, Md.)|December 28, 2016
Analysis of surgical interruption of the enterohepatic circulation as a treatment for pediatric cholestasisKasper S Wang, Greg Tiao, Lee M Bass, et al.
JHEP Reports : Innovation in Hepatology|June 26, 2026
Longitudinal GGT Trajectories Identify Prognostic Phenotypes in Paediatric Primary Sclerosing CholangitisDaniela Denier, Yiming Emmett Peng, Mansi Amin, et al.
Hepatology Communications|January 5, 2024
Protein biomarkers GDF15 and FGF21 to differentiate mitochondrial hepatopathies from other pediatric liver diseasesJohan L K Van Hove, Marisa W Friederich, Dana K Strode, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 4, 2020
Colorectal Dysplasia and Cancer in Pediatric-Onset Ulcerative Colitis Associated With Primary Sclerosing CholangitisWael El-Matary, Stephen L Guthery, Achiya Z Amir, et al.
Hepatology Communications|April 1, 2026
CD8 TRM-like T cells expressing perforin and IFN-γ define a pediatric activated T-cell acute liver failure endotypeTamir Diamond, Catherine A Chapin, Caroline J Diorio, et al.
Hepatology (Baltimore, Md.)|September 18, 2020
Oral Vancomycin, Ursodeoxycholic Acid, or No Therapy for Pediatric Primary Sclerosing Cholangitis: A Matched AnalysisMark R Deneau, Cara Mack, Douglas Mogul, et al.
Hepatology (Baltimore, Md.)|January 22, 2019
Identification of Polycystic Kidney Disease 1 Like 1 Gene Variants in Children With Biliary Atresia Splenic Malformation SyndromeJohn-Paul Berauer, Anya I Mezina, David T Okou, et al.
Hepatology (Baltimore, Md.)|May 19, 2021
Recurrence of Primary Sclerosing Cholangitis After Liver Transplant in Children: An International Observational StudyMercedes Martinez, Emily R Perito, Pamela Valentino, et al.
JHEP Reports : Innovation in Hepatology|July 17, 2023
Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasisRichard J Thompson, Reha Artan, Ulrich Baumann, et al.
Alimentary Pharmacology & Therapeutics|March 11, 2024
Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis-associated inflammatory bowel disease (PSC-IBD): A matched analysis from the Paediatric PSC ConsortiumAmanda Ricciuto, Kuan Liu, Wael El-Matary, et al.
Pageof 20